Granules India Ltd
GRANULESBSE 532482PharmaceuticalsMkt cap ₹20,339 Cr
Whole group, including subsidiaries — the figures companies headline.
Revenue · Q1 FY27
₹1,477 Cr
YoY +22.0%QoQ +0.4%
Net profit · Q1 FY27
₹180 Cr
YoY +59.8%QoQ -10.7%
Net margin · Q1 FY27
12.2%
+2.9 pts vs Q1 FY26
Net profit · FY26
₹595 Cr
YoY +18.6%
Quarterly results
| ₹ Cr | Q1 FY27 Apr–Jun 2026 | Q4 FY26 Jan–Mar 2026 | Q3 FY26 Oct–Dec 2025 | Q2 FY26 Jul–Sep 2025 | Q1 FY26 Apr–Jun 2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | 1,477 | 1,471 | 1,388 | 1,297 | 1,210 | +22.0% |
| Other income | 2.27 | 8.77 | -3.64 | -1.15 | 16.35 | -86.1% |
| Total income | 1,479 | 1,479 | 1,384 | 1,296 | 1,226 | +20.6% |
| Profit before tax | 240 | 262 | 202 | 176 | 145 | +66.3% |
| Tax | 60.44 | 60.79 | 52.02 | 45.26 | 31.89 | +89.5% |
| Net profit | 180 | 202 | 150 | 131 | 113 | +59.8% |
| Net margin | 12.2% | 13.7% | 10.8% | 10.1% | 9.3% |
Annual results
| ₹ Cr | FY26 Apr 2025–Mar 2026 | FY25 Apr 2024–Mar 2025 | FY24 Apr 2023–Mar 2024 | FY23 Apr 2022–Mar 2023 | FY22 Apr 2021–Mar 2022 | YoY |
|---|---|---|---|---|---|---|
| Revenue | 5,366 | 4,482 | 4,506 | 4,512 | 3,765 | +19.7% |
| Other income | 20.33 | 12.92 | 4.40 | 13.78 | 17.61 | +57.4% |
| Total income | 5,386 | 4,495 | 4,511 | 4,526 | 3,783 | +19.8% |
| Profit before tax | 785 | 660 | 547 | 687 | 558 | +18.9% |
| Tax | 190 | 159 | 142 | 171 | 145 | +19.7% |
| Net profit | 595 | 502 | 405 | 517 | 413 | +18.6% |
| Net margin | 11.1% | 11.2% | 9.0% | 11.4% | 11.0% |
BIC's take
We haven't covered Granules India Ltd yet. Browse our sector reports →
Source: BSE filings · Data as of 2 Oct 2026, 5:52 pm IST· ₹ crore unless stated. Covers BSE 500 companies only. Consolidated figures include subsidiaries; standalone is the parent company alone. Growth is shown only against a positive base. Not investment advice — check the company's full filing before acting.